Does UPMC Health Plan Cover Mounjaro?
The verdict
Conditional on most plans
UPMC Health Plan (University of Pittsburgh Medical Center) covers Mounjaro for type 2 diabetes with prior authorization across commercial, ACA, and Medicare lines in western Pennsylvania. Mounjaro is not covered for weight loss. PA Medicaid dropped adult weight-loss GLP-1 coverage in 2025, but Mounjaro for T2D with PA continues. The weight-loss tirzepatide is Zepbound, with separate coverage.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with UPMC Health Plan using your member ID.
Key facts
UPMC Health Plan is owned by the University of Pittsburgh Medical Center — a provider-owned integrated plan, meaning UPMC providers can often coordinate prior authorizations internally for UPMC patients.
UPMC Health Plan plan documentation
Pennsylvania Medicaid dropped adult weight-loss GLP-1 coverage in 2025. Mounjaro for type 2 diabetes with PA is still covered; Zepbound for weight loss is not covered under PA Medicaid.
Pennsylvania Department of Human Services, Medicaid PDL update, 2025
The 2026 Medicare Part D out-of-pocket cap is $2,100. Most continuous Mounjaro users for diabetes reach the cap within 2-3 months and pay $0 for the rest of the year.
CMS.gov, Medicare Part D Redesign 2026
Medicare vs. commercial coverage
Whether UPMC Health Plan covers Mounjaro depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
UPMC Health Plan Medicare Part D and Medicare Advantage plans cover Mounjaro for type 2 diabetes only — not weight loss — at a specialty or non-preferred tier with prior authorization. The 2026 Part D out-of-pocket cap is $2,100; most continuous users reach it within 2-3 months and pay $0 thereafter. The IRA-negotiated Medicare MFN price of $245/month begins mid-2026. Mounjaro is NOT in the 2026 Medicare GLP-1 Bridge, which covers weight-loss-approved products only. The Lilly savings card is not usable by Medicare beneficiaries.
Commercial / Employer
Group & marketplace plans
UPMC Health Plan Commercial/Employer plans cover Mounjaro for type 2 diabetes with prior authorization. Off-label weight-loss use is not covered. ACA/Individual: covered for T2D with PA; weight-loss GLP-1s are commonly excluded. Medicaid (PA): Pennsylvania Medicaid dropped adult weight-loss GLP-1 coverage in 2025 — Mounjaro is still covered for T2D with PA at nominal Medicaid cost-share. Weight-loss use is excluded. The Lilly savings card ($25/month with coverage; $499/month without) applies to commercially insured patients only, not government programs.
The 5 boxes you must tick to get approved
Commercial plans that will consider Mounjaro require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
0 of 5 requirements selected. Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Mounjaro actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Approximately $1,300–$1,560/month retail (WAC ~$1,080). Lilly savings card: $499/month for commercially insured without coverage (max $647/month; up to 13 fills; expires 12/31/2026). Not available to Medicare or Medicaid beneficiaries.
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial with coverage: Lilly savings card as low as $25/month. Medicare Part D: 25% coinsurance after deductible until the $2,100 OOP cap; most continuous users reach the cap in 2-3 months. MFN price $245/month mid-2026 for Medicare. PA Medicaid: nominal cost-share for T2D coverage.
Typical monthly copay once prior authorization is approved.
All figures are estimates; actual cost-share varies by plan tier and pharmacy. Verify on your UPMC Health Plan formulary or member services.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Look up Mounjaro on the UPMC Health Plan formulary
Visit upmchealthplan.com and use the drug formulary search for your specific commercial, Medicare, or Medicaid plan. Search for 'Mounjaro' or 'tirzepatide' and confirm it is listed for diabetes (ICD-10 E11.x). Note the tier, prior authorization requirement, and any quantity limits.
- 2
Work with your prescriber on the PA submission
Your prescriber must document your confirmed T2D diagnosis, A1c of 6.5% or higher, and prior use of metformin or a documented contraindication. Because UPMC Health Plan is a provider-owned integrated plan, your UPMC provider can coordinate the PA internally. Allow up to 72 hours for standard review.
- 3
Call UPMC Health Plan member services to confirm coverage and PA status
Call the number on the back of your UPMC Health Plan card. Ask: Is Mounjaro covered for type 2 diabetes on my plan? What tier and copay apply? Is Mounjaro covered for weight loss? (Answer: No — diabetes-only. The weight-loss tirzepatide is Zepbound, covered separately.) If you are on PA Medicaid, confirm T2D-only coverage given the 2025 adult weight-loss GLP-1 exclusion.
Options if UPMC Health Plan won't cover Mounjaro
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Ozempic (semaglutide)
FDA-approved for type 2 diabetes. Commonly covered on UPMC Health Plan formularies with prior authorization, often at a preferred tier.
Trulicity (dulaglutide)
FDA-approved for T2D. GLP-1 alternative frequently on preferred tiers with lower list price than Mounjaro.
Jardiance (empagliflozin)
SGLT2 inhibitor approved for T2D with cardiovascular benefits. Often covered at preferred tiers on UPMC commercial and PA Medicaid plans.
Zepbound (tirzepatide) — weight loss only
Same molecule as Mounjaro (tirzepatide) but FDA-approved for chronic weight management — not diabetes. Pennsylvania Medicaid dropped adult weight-loss GLP-1 coverage in 2025, limiting Zepbound access on PA Medicaid. Coverage requires a separate weight-loss indication approval.
These options are listed for information only — your own clinician decides what is appropriate for you.
Frequently Asked Questions
No. UPMC Health Plan does not cover Mounjaro for weight loss under any line of business. Mounjaro is FDA-approved for type 2 diabetes only. Off-label weight-loss requests are denied. For weight loss, the same active ingredient (tirzepatide) is sold as Zepbound. Pennsylvania Medicaid dropped adult weight-loss GLP-1 coverage in 2025, further restricting access to weight-loss tirzepatide on PA Medicaid.
Both UPMC Health Plan and Highmark are major western Pennsylvania carriers with similar Mounjaro coverage — diabetes only, prior authorization required. The key difference is that Highmark is a multi-state BCBS licensee (PA/DE/WV/NY) while UPMC is a provider-owned, UPMC-integrated plan concentrated in western PA. Both plans are affected by the 2025 Pennsylvania Medicaid adult weight-loss GLP-1 exclusion.
Yes, for type 2 diabetes. Pennsylvania Medicaid dropped adult weight-loss GLP-1 coverage in 2025 — but Mounjaro for T2D with prior authorization is still covered at nominal Medicaid cost-share. Weight-loss use is excluded. If you are on a UPMC Medicaid plan, verify T2D-only coverage on your plan formulary or call member services.
UPMC Health Plan requires a confirmed type 2 diabetes diagnosis (ICD-10 E11.x), A1c of 6.5% or greater, and documented trial or failure of metformin (and often one additional agent). Patient must be 18 or older. Quantity limit is typically 4 pens per 28 days. Because UPMC is provider-owned, your UPMC prescriber can often coordinate the PA internally. Verify criteria on the UPMC Health Plan formulary.
Only if you have a UPMC commercial (employer-sponsored or individual) plan, not Medicare or Medicaid. Commercially insured members with Mounjaro coverage may pay as little as $25/month; without coverage, $499/month (max $647/month; up to 13 fills; expires 12/31/2026). The card is not available to UPMC Medicare Part D, Medicare Advantage, or PA Medicaid beneficiaries.
Related Articles
Does Security Health Plan Cover Mounjaro? 2026 | Curex
Security Health Plan (WI) covers Mounjaro for type 2 diabetes with prior auth — not weight loss. Composite pattern; verify on plan formulary.
Read moreDoes Geisinger Health Plan Cover Mounjaro? 2026 Guide | Curex
Geisinger covers Mounjaro for type 2 diabetes with prior auth — not weight loss. PA Medicaid is diabetes-only after the 2025 weight-loss GLP-1 cut.
Read moreDoes Tufts Health Plan Cover Mounjaro? 2026 Guide | Curex
Tufts Health Plan covers Mounjaro for type 2 diabetes with prior auth — not weight loss. MA Medicaid covers diabetes; weight-loss GLP-1s restricted.
Read moreDoes UPMC Health Plan Cover Ozempic? 2026 Guide | Curex
UPMC Health Plan covers Ozempic for T2D with prior auth — PA may reflect UPMC clinical protocols. Weight-loss excluded. Formulary, PA steps, 2026 costs.
Read moreDoes Harvard Pilgrim Health Care Cover Mounjaro? 2026 | Curex
Harvard Pilgrim (Point32Health) covers Mounjaro for type 2 diabetes with PA — not weight loss. MA Medicaid covers diabetes; weight-loss GLP-1s restricted.
Read moreDoes Health Net Cover Mounjaro? California 2026 | Curex
Health Net (Centene, CA) covers Mounjaro for type 2 diabetes with prior auth — not weight loss. Medi-Cal excludes weight-loss GLP-1s from 1/1/2026.
Read moreInsurance covers Mounjaro only for diabetes — for weight loss, here's a path that skips insurance
You just saw how tangled Mounjaro coverage can get — auto-rejections, prior authorization, and high cash prices. Curex compounded semaglutide: $199/month equivalent prepaid annually ($2,388 upfront), or $299/month paid monthly. Compounded tirzepatide: $299/month equivalent prepaid annually ($3,588 upfront), or $399/month paid monthly. Commercial rates as of 2026-10-12; compounded products are not FDA-approved and clinical eligibility must be assessed. Curex compounded medications are not the same as Mounjaro. No insurance or prior authorization required; prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Mounjaro and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with UPMC Health Plan before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Mounjaro and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.